NEW YORK (Reuters) - Eli Lilly said on Thursday U.S. regulators approved the use of Cymbalta, its blockbuster anti-depressant drug, for chronic musculoskeletal pain, including lower back pain and ...
The U.S. Food and Drug Administration has approved Cymbalta for chronic back pain and osteoarthritis pain, according to a FDA news release. Cymbalta, which was first used to treat major depressive ...
The Food and Drug Administration recently approved Cymbalta (duloxetine hydrochloride) to treat chronic musculoskeletal pain, including discomfort from osteoarthritis and chronic lower back pain. The ...
CHICAGO (Reuters) - Eli Lilly and Co said on Friday it withdrew an application to market its anti-depressant Cymbalta for the management of chronic pain because U.S. health regulators raised questions ...
Many with peripheral neuropathy use medications like Gabapentin, Lyrica, or Cymbalta for relief, but these only mask symptoms instead of treating the cause. While they may temporarily reduce pain, ...
Indianapolis - Cymbalta may have been launched as an anti-depressant, but it offers relief for low back pain. According to our news gathering partners at the Indianapolis Star, that announcement came ...
DEAR DR. ROACH: I’ve been on Cymbalta for 16 years. I had had panic attacks, and my doctor suggested it, along with talk therapy. After a year, my therapist told me they weren’t made to be used long ...
The Next Prozac? Consumers may soon be facing an ad barrage for the antidepressant Cymbalta, approved this month by the Food and Drug Administration. Financial analysts say maker Eli Lilly & Co. is ...
Cymbalta (duloxetine) is a prescription drug that treats major depressive disorder, anxiety disorder, and other conditions. Its cost may depend on factors such as dosage, whether you have health ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback